Clinical Trial: Evaluation of Fisetin to Reduce Systemic Senescence

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918261) titled 'Evaluation of Fisetin to Reduce Systemic Senescence' on Oct. 21.

Brief Summary: This is a prospective, randomized clinical trial to evaluate the ability of the supplement, Fisetin, to safely reduce systemic senescence (aging) indices assessed in peripheral blood.

Study Start Date: May 24, 2023

Study Type: INTERVENTIONAL

Condition: Cellular Senescence

Intervention: DRUG: Fisetin (daily dosing)

Oral Fisetin 100mg capsule

DRUG: Fisetin (bolus dosing)

Oral Fisetin 100mg capsule, dosed at 20 mg/kg

Recruitment Status: COMPLETED

Sponsor: Steadman Philippon Research Institute

Disclaimer: Curated by HT Syndication....